Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases.

The management of these diseases has made remarkable advancements in previous years, but the burden on patients remains high, posing a need to develop novel therapeutics and delivery mechanisms that improve the efficacy and durability of anti-VEGF drugs and beyond.

Providing you with an in-depth coverage of technical insights of anti-VEGF, innovative non-VEGF targeting therapeutics for wet-AMD, DME, DR and RVO, the Retinal Vascular Disease Drug Development Summit will address the specific challenges in utilizing preclinical models for retinal vascular disease, understand key regulatory requirements, and learn how to run effective clinical trials that utilize appropriate endpoints.

Join your colleagues from across R&D, preclinical, translational and clinical teams across the biopharmaceutical industry to streamline your drug development and address the significant and increasing unmet medical need.

To know more visit: https://ter.li/7xp7xc